首页> 外文期刊>Gastrointestinal Endoscopy >Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures: is there a difference?
【24h】

Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures: is there a difference?

机译:镍钛诺和不锈钢裸露金属支架治疗恶性胆道狭窄的临床结果:有区别吗?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Self-expandable metal stents (SEMSs) made from nitinol (N) were developed as a potentially more effective alternative to conventional stainless steel (SS) stents. OBJECTIVE: To compare clinical outcomes of N versus SS stents in the management of malignant biliary strictures. DESIGN: Retrospective study. SETTING: Tertiary-care cancer center. PATIENTS: All patients with first-time N (Flexxus) and SS (Wallstent) uncovered biliary SEMSs placed between January 2006 and October 2007. INTERVENTIONS: SEMS placement. RESULTS: A total of 81 N and 96 SS stents were placed. The most common cancer diagnosis was pancreatic (80.2% N; 62.5% SS; P = .06). The most frequent site of stricture was the common bile duct (85.2% N; 86.5% SS; P = .31). Biliary decompression was achieved in 93.8% of the N group and 86.4% of the SS group (P = .22). Immediate stent manipulation was required in 4 patients in each group. Subsequent intervention for poor drainage was performed in 17 N (21%) and 26 SS (27%) stents at mean times of 142.1 days (range, 5-541 days; median, 77 days) and 148.1 days (range, 14-375; median, 158.5), respectively (P = .17). The occlusion rate between N and SS stents was not significant (P = .42). The overall durations of stent patency in the N and SS group were similar (median 129 and 137 days, respectively; P = .61), including the subgroup analysis performed on patients with pancreatic cancer (P = .60) and common duct strictures (P = .77). Complication rates were low in both groups (early: 3.7% N, 6.3% SS; late: 2.5% N, 3.1% SS). Ninety percent underwent chemotherapy and 38% radiation therapy in each group. LIMITATIONS: Retrospective design. CONCLUSION: Similar outcomes were achieved with N and SS stents regarding efficacy, duration of stent patency, occlusion rates, and complications. Our results are most applicable to patients with common duct strictures and pancreatic cancer.
机译:背景:由镍钛诺(N)制成的自膨胀金属支架(SEMS)被开发为替代常规不锈钢(SS)支架的潜在更有效的替代品。目的:比较N支架和SS支架治疗恶性胆道狭窄的临床效果。设计:回顾性研究。单位:三级癌症中心。患者:2006年1月至2007年10月之间,所有首次N(Flexxus)和SS(Wallstent)的患者均未发现胆管SEMS。干预措施:SEMS放置。结果:总共放置了81个N支架和96个SS支架。最常见的癌症诊断是胰腺癌(N为80.2%; SS为62.5%; P = 0.06)。狭窄的最常见部位是胆总管(N占85.2%; SS占86.5%; P = 0.31)。 N组的胆汁减压达到93.8%,SS组的胆汁减压达到86.4%(P = 0.22)。每组4名患者需要立即进行支架操作。随后对17 N(21%)和26 SS(27%)支架进行了引流不良的干预,平均时间为142.1天(范围:5-541天;中位数:77天)和148.1天(范围:14-375天) ;中位数分别为158.5)(P = .17)。 N和SS支架之间的阻塞率不显着(P = .42)。 N组和SS组的支架通畅的总持续时间相似(分别为中位数129天和137天; P = 0.61),包括对胰腺癌(P = 0.60)和普通管狭窄的患者进行的亚组分析(P = 0.60)。 P = 0.77)。两组的并发症发生率均较低(早期:N 3.7%,SS 6.3%;晚期:N 2.5%,SS 3.1%)。每组中百分之九十接受化学疗法,百分之38接受放射疗法。局限性:回顾性设计。结论:N和SS支架在疗效,支架通畅时间,闭塞率和并发症方面取得了相似的结果。我们的结果最适用于患有普通管狭窄和胰腺癌的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号